These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7030898)

  • 21. Does residual insulin secretion (assessed by C-peptide concentration) affect lipid and lipoprotein levels in insulin-dependent diabetes mellitus?
    Winocour PH; Durrington PN; Ishola M; Gordon C; Jeacock J; Anderson DC
    Clin Sci (Lond); 1989 Oct; 77(4):369-74. PubMed ID: 2680233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of anti-insulin antibodies and of peptide C residual secretion on the metabolic control of diabetes type 1].
    Velasco N; Díaz de Valdés M; Arteaga A; Acosta AM; Pellegrini MR; Foradori A
    Rev Med Chil; 1990 Jan; 118(1):3-9. PubMed ID: 2152698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of the beta cell function in type I diabetes by the determination of peptide C after glucagon challenge].
    Alpigiani MG; Gandullia E; Lattere M; De Grandi R; Bonioli E
    Pediatr Med Chir; 1990; 12(3):239-41. PubMed ID: 2274434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes complications and glycemic control. The Pittsburgh Prospective Insulin-Dependent Diabetes Cohort Study Status Report after 5 yr of IDDM.
    D'Antonio JA; Ellis D; Doft BH; Becker DJ; Drash AL; Kuller LH; Orchard TJ
    Diabetes Care; 1989; 12(10):694-70. PubMed ID: 2612304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypersensitivity to insulin during remissions in cyclosporin-treated IDDM patients.
    Burcelin RG; Eddouks M; Beylot M; Normand S; Boitard C; Feutren G; Landais P; Riou JP; Girard JR; Bach JF
    Diabetes Care; 1993 Jun; 16(6):881-8. PubMed ID: 8325202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Free insulin, bound insulin, C-peptide and the metabolic control in juvenile onset diabetics: comparison of C-peptide secretors and non-secretors during 24 hours conventional insulin therapy.
    Gerbitz KD; Kemmler W; Edelmann A; Summer J; Mehnert H; Wieland OH
    Eur J Clin Invest; 1979 Dec; 9(6):475-83. PubMed ID: 119646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proinsulin/C-peptide ratio, glucagon and remission in new-onset Type 1 diabetes mellitus in young adults.
    Schölin A; Nyström L; Arnqvist H; Bolinder J; Björk E; Berne C; Karlsson FA;
    Diabet Med; 2011 Feb; 28(2):156-61. PubMed ID: 21219422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of residual endogenous insulin secretion on the abnormal oxytocin response to hypoglycaemia in insulin-dependent diabetics.
    Volpi R; Chiodera P; Capretti L; Caffarri G; Giuliani N; Caiazza A; Coiro V
    J Intern Med; 1998 Jul; 244(1):43-8. PubMed ID: 9698023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between insulin antibodies and metabolic control in type I diabetes mellitus.
    Moisés RS; Sá JR; Chacra AR; Russo EM
    Braz J Med Biol Res; 1990; 23(12):1243-52. PubMed ID: 2136556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-peptide secretion and insulin antibodies as determinants of stability in diabetes mellitus.
    Yue DK; Baxter RC; Turtle JR
    Metabolism; 1978 Jan; 27(1):35-44. PubMed ID: 619224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial.
    Pinckney A; Rigby MR; Keyes-Elstein L; Soppe CL; Nepom GT; Ehlers MR
    Clin Ther; 2016 Jun; 38(6):1327-1339. PubMed ID: 27209482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of bacille Calmette-Guérin vaccination on C-peptide secretion in children newly diagnosed with IDDM.
    Elliott JF; Marlin KL; Couch RM
    Diabetes Care; 1998 Oct; 21(10):1691-3. PubMed ID: 9773732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenetic and nutritional profile in insulin-using youth-onset diabetics in Korea.
    Huh KB; Lee HC; Kim HM; Cho YW; Kim YL; Lee KW; Lee EJ; Lim SK; Kim DH; Yoon JW
    Diabetes Res Clin Pract; 1992 Apr; 16(1):63-70. PubMed ID: 1576933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study).
    Pozzilli P; Visalli N; Signore A; Baroni MG; Buzzetti R; Cavallo MG; Boccuni ML; Fava D; Gragnoli C; Andreani D
    Diabetologia; 1995 Jul; 38(7):848-52. PubMed ID: 7556988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of the ligand immunofunctional assay for human insulin-like growth factor ((IGF) binding protein-3 (IGFBP-3) to analyze IGFBP-3 proteolysis and igf-i bioavailability in healthy adults, GH-deficient and acromegalic patients, and diabetics.
    Lassarre C; Duron F; Binoux M
    J Clin Endocrinol Metab; 2001 May; 86(5):1942-52. PubMed ID: 11344189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
    Shilo S; Sotsky M; Shamoon H
    J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biological significance of the endogenous secretion of insulin in response to breakfast in diabetic children].
    Gualda P; Fernández JM; Rubio R; Osuna JI; Molina-Font JA; Castillo M
    An Esp Pediatr; 1987 Nov; 27(5):347-51. PubMed ID: 3326443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence of insulin autoantibodies at clinical diagnosis of diabetes mellitus type I predicts loss of beta cell function.
    Gomis R; Recasesns A; Peig M; Casamitjana R; Pujol-Borrell R; Rivera F; Vilardell E
    Autoimmunity; 1988; 1(4):299-305. PubMed ID: 2979623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epinephrine in humans.
    Berk MA; Clutter WE; Skor D; Shah SD; Gingerich RP; Parvin CA; Cryer PE
    J Clin Invest; 1985 Jun; 75(6):1842-51. PubMed ID: 3891786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients.
    Kruszynska YT; Goulas S; Wollen N; McIntyre N
    J Hepatol; 1998 Feb; 28(2):280-91. PubMed ID: 9514541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.